FDA Inspection 1170196 — Albert Einstein Healthcare Network IRB

Albert Einstein Healthcare Network IRB — FEI 2518769

The FDA completed an inspection of Albert Einstein Healthcare Network IRB on May 9, 2022 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 9, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

IRB